Interest in psychedelic molecules is at an all-time high, and debate around the necessity of the subjective effects of hallucinogenic compounds is in full swing.1,2 The stage has been set for psychedelic analogs, compounds that structurally mimic a molecule of interest. With the lights turned on to better therapeutic solutions for mental health and addiction, 18-Methoxycoronaridine (18-MC) has the…
